An observational study in Corneal Dystrophy, sponsored by Frederiksberg University Hospital. Status unknown at 1 site in Denmark. Per ClinicalTrials.gov, last updated 2010-03-11.
Sponsored by Frederiksberg University Hospital · Observational
The purpose of this study is to compare corneal endothelium morphology and central thickness in type II Diabetes Mellitus and normal subjects with special reference to glycemic status.
Diabetes might influence the health of the corneal endothelium. Older studies have presented different results and the glycemic status of the patients have not been reported. In this study we examine the corneal endothelium morphology and central thickness in type II Diabetes Mellitus and normal subjects with modern specular microscopy. Each patient and control is examined once ("entry to study").
58 studies on the registry are indexed under Corneal Dystrophies, Hereditary; 11 are open to participants now.
This study's planned enrollment of 300 is above the median of 213 across 20 observational studies indexed under Corneal Dystrophies, Hereditary.
Browse Corneal Dystrophies, Hereditary studies →Frederiksberg University Hospital is the lead sponsor of 40 studies on the registry; 1 is open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients visiting Frederiksberg hospital for any reason
Exclusion Criteria:
Patients with type 2 Diabetes Mellitus
Patients with no diabetes
Corneal endothelium cell number
The study is a cross-sectional study. We compare a cohort of patients with DM to a cohort with no DM. We examine each patient and control once. We call time of appointment or examination for "at entry to study".
Time frame: 1 year
Corneal endothelium morphology
The size and hexagonality of the cells are analysed automaticly by computer recognizion.
Time frame: 1 year
This study is status unknown, as verified in Jan 2010. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Corneal Dystrophies, Hereditary→
Frederiksberg University Hospital